皮肤检测细胞衰竭病的皮肤测试.

Real-world prognostic assessment of the HERO score in metastatic urothelial carcinoma treated with enfortumab vedotin (ARON-2EV study).

ESMO open·2026

Stress and brain functional changes in patients with Crohn's disease: A functional magnetic resonance imaging study.

Neurogastroenterology and motility·2017

Risk of permanent stoma in extensive Crohn's colitis: the impact of biological drugs.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2013

Randomized controlled trials in pouchitis.

Reviews on recent clinical trials·2012

New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry study.

Neurogastroenterology and motility·2012

Distinct proteomic profiles characterise non-erosive from erosive reflux disease.

Alimentary pharmacology & therapeutics·2011

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Mogroside-Rich Monk Fruit Extract Improves Glycemic Control Without Promoting Additional Weight Gain Compared With Sucralose and Sucrose in High-Fat Diet-Induced Obese Mice.

Food science & nutrition·2026

Affective factors predicting Binge Eating Disorder: The role of emotion regulation, impulsivity, and cognitive distortions.

Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi·2026

Temporal gut microbiota dysbiosis links metabolic impairment, LDL desialylation, and accelerated atherosclerosis in LDLR<sup>-</sup>/<sup>-</sup> mice.

Frontiers in medicine·2026

Friend or Foe: Dietary Restriction and Its Protective Effects on Responses to Ionizing Radiation.

Dose-response : a publication of International Hormesis Society·2026

The effects of 12-weeks resveratrol supplementation on cognition, gastrointestinal microbiota, and systemic inflammation, in an overweight and obese human population: a randomized, double-blind, placebo controlled, parallel groups trial.

Frontiers in nutrition·2026

Dietary pattern modifies associations between dietary factors and pace of epigenetic aging.

Frontiers in nutrition·2026

相关实验视频

皮肤检测细胞衰竭病的皮肤测试.

相关概念视频

Real-world prognostic assessment of the HERO score in metastatic urothelial carcinoma treated with enfortumab vedotin (ARON-2EV study).

Stress and brain functional changes in patients with Crohn's disease: A functional magnetic resonance imaging study.

Risk of permanent stoma in extensive Crohn's colitis: the impact of biological drugs.

Randomized controlled trials in pouchitis.

New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry study.

Distinct proteomic profiles characterise non-erosive from erosive reflux disease.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Mogroside-Rich Monk Fruit Extract Improves Glycemic Control Without Promoting Additional Weight Gain Compared With Sucralose and Sucrose in High-Fat Diet-Induced Obese Mice.

Affective factors predicting Binge Eating Disorder: The role of emotion regulation, impulsivity, and cognitive distortions.

Temporal gut microbiota dysbiosis links metabolic impairment, LDL desialylation, and accelerated atherosclerosis in LDLR<sup>-</sup>/<sup>-</sup> mice.

Friend or Foe: Dietary Restriction and Its Protective Effects on Responses to Ionizing Radiation.

The effects of 12-weeks resveratrol supplementation on cognition, gastrointestinal microbiota, and systemic inflammation, in an overweight and obese human population: a randomized, double-blind, placebo controlled, parallel groups trial.

Dietary pattern modifies associations between dietary factors and pace of epigenetic aging.

相关实验视频

皮肤检测细胞衰竭病的皮肤测试.

相关概念视频

相关文章